H Lundbeck A/S at JPMorgan Healthcare Conference Transcript
Good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, I've got the pleasure of introducing the Lundbeck presentation. So we're going to hear from Lundbeck's CEO, Deborah Dunsire, and we've got a 20-minute presentation, and then we'll leave 20 minutes for Q&A, which is going to take place in here. And you can try and log your questions on the website or you can put up your hand, and we'll take your question.
With that said, thanks a lot for joining us, Deborah. Look forward to the presentation.
/-&
Great. Thank you, James. Well, happy new year to everybody. It's great to be back in-person in a lot of ways, and I'm very, very happy to be presenting Lundbeck here today. So you've seen our forward-looking statements, so I don't have to spend any time on those.
It's exciting times to be active in neuroscience, and Lundbeck has
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
